Senior Leadership


Judith Klimovsky, M.D.

Argentinian (U.S. Citizen)
Executive Vice President & Chief Development Officer

Dr. Klimovsky joined Genmab in 2017 and is a recognized drug developer with more than 10 years of experience in R&D leadership roles in big pharma. She has successfully led the development of key cancer drugs at both Bristol-Myers Squibb and Novartis from early clinic through late stage development and approval including ixabepilone (BMS), ASA404, MEK162, LGX818 and Afinitor (Novartis). During the span of her career, she has led global R&D organizations of over 450 people. Dr. Klimovsky has been a board member of Bellicum Pharmaceuticals since January 2019. Previously, Dr. Klimovsky served in various hematology clinical practice positions in Buenos Aires, Argentina. Dr. Klimovsky earned her M.D. from the Buenos Aires University School of Medicine. As a medical doctor she also brings skills and experience from working as a clinician in hospital environments.

Back To Senior Leadership